Single-cell cancer detection project wins 2021 NEMO Prize
Penn Health-Tech’s Nemirovsky Engineering and Medicine Opportunity (NEMO) Prize awards $80,000 to support early-stage ideas joining engineering and medicine. This year, the NEMO Prize has been awarded to a team of researchers from Penn Engineering’s Department of Bioengineering, with a project that aims to develop a technology that can detect multiple cancer biomarkers in single cells from tumor biopsy samples.
FULL STORY AT Penn Engineering Today →